BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 35293857)

  • 1. SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome.
    Zaffagni M; Harris JM; Patop IL; Pamudurti NR; Nguyen S; Kadener S
    Elife; 2022 Mar; 11():. PubMed ID: 35293857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome.
    Zaffagni M; Harris JM; Patop IL; Pamudurti NR; Nguyen S; Kadener S
    bioRxiv; 2022 Feb; ():. PubMed ID: 35194610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2.
    Ogando NS; Zevenhoven-Dobbe JC; van der Meer Y; Bredenbeek PJ; Posthuma CC; Snijder EJ
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling.
    Li TW; Kenney AD; Park JG; Fiches GN; Liu H; Zhou D; Biswas A; Zhao W; Que J; Santoso N; Martinez-Sobrido L; Yount JS; Zhu J
    Front Immunol; 2022; 13():1007089. PubMed ID: 36177032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition.
    Pan R; Kindler E; Cao L; Zhou Y; Zhang Z; Liu Q; Ebert N; Züst R; Sun Y; Gorbalenya AE; Perlman S; Thiel V; Chen Y; Guo D
    mBio; 2022 Feb; 13(1):e0366221. PubMed ID: 35073761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenesis of Coronavirus nsp14 Reveals Its Potential Role in Modulation of the Innate Immune Response.
    Becares M; Pascual-Iglesias A; Nogales A; Sola I; Enjuanes L; Zuñiga S
    J Virol; 2016 Jun; 90(11):5399-5414. PubMed ID: 27009949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenesis of S-Adenosyl-l-Methionine-Binding Residues in Coronavirus nsp14 N7-Methyltransferase Demonstrates Differing Requirements for Genome Translation and Resistance to Innate Immunity.
    Case JB; Ashbrook AW; Dermody TS; Denison MR
    J Virol; 2016 Aug; 90(16):7248-7256. PubMed ID: 27252528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry.
    Pearson LA; Green CJ; Lin D; Petit AP; Gray DW; Cowling VH; Fordyce EAF
    SLAS Discov; 2021 Jul; 26(6):749-756. PubMed ID: 33724070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function analysis of the nsp14 N7-guanine methyltransferase reveals an essential role in
    Ogando NS; El Kazzi P; Zevenhoven-Dobbe JC; Bontes BW; Decombe A; Posthuma CC; Thiel V; Canard B; Ferron F; Decroly E; Snijder EJ
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2.
    Saramago M; Bárria C; Costa VG; Souza CS; Viegas SC; Domingues S; Lousa D; Soares CM; Arraiano CM; Matos RG
    FEBS J; 2021 Sep; 288(17):5130-5147. PubMed ID: 33705595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19.
    Selvaraj C; Dinesh DC; Panwar U; Abhirami R; Boura E; Singh SK
    J Biomol Struct Dyn; 2021 Aug; 39(13):4582-4593. PubMed ID: 32567979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry.
    Scholle MD; Liu C; Deval J; Gurard-Levin ZA
    SLAS Discov; 2021 Jul; 26(6):766-774. PubMed ID: 33870746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase.
    Ahmed-Belkacem R; Sutto-Ortiz P; Guiraud M; Canard B; Vasseur JJ; Decroly E; Debart F
    Eur J Med Chem; 2020 Sep; 201():112557. PubMed ID: 32563813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Platforms for Characterizing and Targeting of SARS-CoV-2 Genome Capping Enzymes.
    Ornelas MY; Thomas AY; Johnson Rosas LI; Scoville RO; Mehta AP
    ACS Synth Biol; 2022 Nov; 11(11):3759-3771. PubMed ID: 36331143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine Hepatitis Virus nsp14 Exoribonuclease Activity Is Required for Resistance to Innate Immunity.
    Case JB; Li Y; Elliott R; Lu X; Graepel KW; Sexton NR; Smith EC; Weiss SR; Denison MR
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein.
    Walter M; Chen IP; Vallejo-Gracia A; Kim IJ; Bielska O; Lam VL; Hayashi JM; Cruz A; Shah S; Soveg FW; Gross JD; Krogan NJ; Jerome KR; Schilling B; Ott M; Verdin E
    PLoS Pathog; 2022 Sep; 18(9):e1010811. PubMed ID: 36095012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein.
    Hsu JC; Laurent-Rolle M; Pawlak JB; Wilen CB; Cresswell P
    Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34045361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nsp14 of SARS-CoV-2 inhibits mRNA processing and nuclear export by targeting the nuclear cap-binding complex.
    Katahira J; Ohmae T; Yasugi M; Sasaki R; Itoh Y; Kohda T; Hieda M; Yokota Hirai M; Okamoto T; Miyamoto Y
    Nucleic Acids Res; 2023 Aug; 51(14):7602-7618. PubMed ID: 37260089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the SARS-CoV-2 NSP14 3'-5' exoribonuclease by NSP10 and response to antiviral inhibitors.
    Riccio AA; Sullivan ED; Copeland WC
    J Biol Chem; 2022 Jan; 298(1):101518. PubMed ID: 34942146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution and functional characterization of SARS-CoV-2 proofreading complex.
    Ma Z; Pourfarjam Y; Kim IK
    Protein Expr Purif; 2021 Sep; 185():105894. PubMed ID: 33933612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.